FDA Adverse Event Injury Summary report: N

PULSE GEN MODEL 103

MDR report key: 2232302 · Received September 2, 2011

Report

Report Number
1644487-2011-02054
Event Type
Injury
Date Received
September 2, 2011
Date of Event
December 1, 2010
Report Date
August 10, 2011
Manufacturer
CYBERONICS INC
Product Code
LYJ
PMA / PMN Number
P970003
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE MANUFACTURING RECORDS WERE REVIEWED. REVIEW OF MANUFACTURING RECORDS CONFIRMED STERILIZATION FOR BOTH THE GENERATOR AND LEAD PRIOR OT DISTRIBUTION. CYBERONICS, INC. SUBMITS THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION, BASED ON INFORMATION THAT CYBERONICS HAS OBTAINED, BUT MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION, OR A CONCLUSION BY FDA OR ANYONE ELSE, THAT THE DEVICE, CYBERONICS, OR CYBERONICS'; EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR "MALFUNCTIONS". THESE WORDS ARE INCORPORATED INTO THE FDA 3500A MEDWATCH FORM BY THE FDA, AND CYBERONICS OBJECTS TO THEIR USE.

Description of Event or Problem · 1

ON (B)(6) 2011 THE MANUFACTURER'S CONSULTANT REPORTED THAT THE VNS PATIENT HAD AN INFECTION AND THE VNS WAS REMOVED ABOUT 4 MONTHS AFTER IMPLANT. THE PATIENT HAD VNS RE-IMPLANTED ON (B)(6) 2011. THE MANUFACTURING RECORDS WERE REVIEWED AND THEY CONFIRMED STERILIZATION FOR BOTH THE GENERATOR AND LEAD PRIOR TO DISTRIBUTION. GOOD FAITH ATTEMPTS FOR ADDITIONAL INFORMATION FROM THE PHYSICIAN HAVE BEEN TO NO AVAIL THUS FAR. WHEN ADDITIONAL INFORMATION IS RECEIVED, IT WILL BE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PULSE GEN MODEL 103 GENERATOR LYJ CYBERONICS INC 103 2518

Patients

Seq Age Sex Outcome Treatment
1 20 YR Required Intervention